Skip to content

Drug interactions

Docetaxel + Finerenone

Severity: Moderate

Docetaxel and Finerenone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Docetaxel is a weak CYP3A4 inhibitor and could modestly raise finerenone levels, increasing the risk of hyperkalemia. Chemotherapy-related renal effects may add to this risk.

What this interaction means in plain words

Docetaxel and Finerenone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Docetaxel belongs to Oncology; Finerenone belongs to Cardiovascular.

Evidence level: Low

Why it happens

Weak CYP3A4 inhibition reduces finerenone metabolism, increasing exposure.

What to do

Monitor serum potassium and renal function during therapy and adjust finerenone dose if hyperkalemia occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Docetaxel and Finerenone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Docetaxel with Finerenone?

MediHelp rates the interaction as moderate. Docetaxel and Finerenone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Docetaxel is a weak CYP3A4 inhibitor and could modestly raise finerenone levels, increasing the risk of hyperkalemia. Chemotherapy-related renal effects may add to this risk.

How serious is the interaction between Docetaxel and Finerenone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium and renal function during therapy and adjust finerenone dose if hyperkalemia occurs.

What other medicines interact with Docetaxel?

MediHelp also lists interactions of Docetaxel with, for example, Adenovirus types 4 and 7 live, Atazanavir, Belatacept. The full list is on the Docetaxel page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in